PATH submitted an application to the World Health Organization (WHO) 21st Expert Committee on the Selection and Use of Essential Medicines to include oxygen on the WHO Model List of Essential Medicines (EML) and the List of Essential Medicines for Children (EMLc) as a medical gas to clarify its importance as a medicine for the management of hypoxemia. This summary document highlights the proposed additions to the EML/EMLc.
Corporate author(s): PATH
Publication date: December 2016
390 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
This publication is part of the series Oxygen technologies
Related regions: Global
- For advocates and policymakers > Child health
- For advocates and policymakers > Health technologies
- Health technologies > Newborn health
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA